期刊文献+

BCAR3诱导乳腺癌上皮间质转化及与癌细胞迁移、侵袭的关系 被引量:6

Breast Cancer Anti-Estrogen Resistance-3 Regulates Breast Cancer Cell Migration and Invasion Through Promotion of Epithelial-Mesenchymal Transition
原文传递
导出
摘要 目的:观察他莫昔芬耐药乳腺癌细胞BCAR3的表达与上皮间质转化(EMT)现象和乳腺癌的迁移侵袭的关系。探讨他莫昔芬耐药和乳腺癌细胞EMT现象的相关性。方法:以实时定量PCR和Western blot检测乳腺癌上皮样和间质样细胞系中BCAR3的表达;Western blot检测乳腺癌MCF-7、MCF-BCAR3和BT-549中介导EMT发生的转录因子Twist、上皮性标记基因E-钙黏素(E-cadherin)和间质性标记基因N-钙黏素(N-cadherin)表达的改变情况。Transwell侵袭实验检测乳腺癌MCF-7、MCF-BCAR3和BT-549侵袭转移能力。结果:BCAR3在乳腺癌上皮样细胞系中的表达明显低于间质样细胞系;E-cadherin蛋白在MCF-7细胞中的表达为阳性,Twist和N-cadherin表达为阴性;他莫昔芬耐药的细胞MCF-BCAR3 E-cadherin蛋白表达缺失,而Twist和N-cadherin表达阳性。BCAR3过度表达导致乳腺癌细胞MCF-7迁移和侵袭能力增强。结论:过度表达BCAR3增强乳腺癌细胞迁移和侵袭能力,并对他莫昔芬治疗产生耐药,可能与BCAR3诱导乳腺癌上皮间质转化有关。 Objective: To investigate the role of breast cancer anti-estrogen resistance-3(BCAR3) in epithelial-mesenchymal transition(EMT) induction of tamoxifen resistant of breast cancer cells,and to determine the relationship between BCAR3 induced tamoxifen resistance and invasiven metastatic behaviors.Methods: Real time PCR and Western blot were used to detect BCAR3 expression levels in epithelium and mesenchymal like breast cancer cell lines.The expression levels of E-cadherin,N-cadherin,and Twist were assessed by Western blot in MCF-7,MCF-BCAR3,and BT-549 cancer cells.Transwell migratory and invasive assays were employed to detect BCAR3 overexpression induced cell migration and invasion.Results: BCAR3 was expressed at higher levels in mesenchymal like-than in epithelial like-breast cancer cell lines.Stable over-expression of BCAR3 in MCF-7 cells leads to downregulation of E-cadherin expression and upregulation of Twist and N-cadherin expression.Coincidently in cells with relatively low migratory potential,BCAR3 overexpression resulted in enhanced migration and invasion.Conclusion: During the development of tamoxifen resistance,BCAR3 may regulate breast cell migration by promotion of EMT,thereby coordinates multiple signaling pathways.
出处 《武汉大学学报(医学版)》 CAS 北大核心 2010年第4期471-475,共5页 Medical Journal of Wuhan University
关键词 乳腺癌 他莫昔芬耐药 BCAR3 上皮间质转化 侵袭 Breast Cancer Tamoxifen Resistance BCAR3 Epithelial-Mesenchymal Transition Invasion
  • 相关文献

参考文献10

  • 1Dorssers LCJ, Van der Flier S, Brinkman A, et al. Tamoxifen resistance in breast cancer., elucidating mechanisms[J]. Drugs, 2001, 61(12):1 721 1 733.
  • 2Clarke R, Skaar TC, Bouker KB, et al. Molecular and pharmacological aspects of antiestrogen resistance[J].J Steroid Biochem Mol Biol, 2001, 76(1 5) :71-84.
  • 3Cai D, Iyer A, Felekkis K, et al. AND-34/BCAR3, a GDP exchange factor whose over expression confers tamoxifen resistance, activates Racl, PAK1 and the cyclin D1 promoter[J]. Cancer Res, 2003, 63(20): 6 802-6 808.
  • 4Thiery JP, AcIoque H, Huang RY, et al Epithelialmesenchymal transitions in development and disease [J]. Cell, 2009, 139(5) :871-890.
  • 5Schmittgen TD, I.ivak KJ. Analyzing real-time PCR data by lhe comparative C(T) method[J]. Nat Protoc, 2008, 3(6):1 101-1 118.
  • 6Riggins RB, Quilliam LA, Bouton AH. Synergistic promotion of c-Src activation and cell migration by Cas and AND-34/BCAR3[J]. J Biol Chem, 2003, 278 (30):28 264-28 273.
  • 7Hiscox S, Morgan L, Barrow D, et al. Tamoxifen resistance in breast cancer cells is accompanied by an en hanced motile and invasive phenotype: inhibition by ge fitinib[J]. Clin Exp Metastasis 2004, 21(3):201-212.
  • 8Near RI, Zhang Y, Makkinje A, et al. AND-34/ BCAR3 differs from other NSP homologs in induction of anti-estrogen resistance, cyclin D1 promoter activation and altered breast cancer cell morphology [J].J Cellular Physiology, 2007, 212(3):655-665.
  • 9SarrioD, Rodriguez Pinilla SM, Hardisson D, et al. Epithelial-mesenchymal transition in breast cancer relates to the basal like phenotype [J]. Cancer Res, 2008. 68(4):989 -997.
  • 10Lan M, Kojima T, Osanai M, et al. Oncogenic Raf-1 regulates epithelial to mesenchymal transition via distinct signal transduction pathways in an immortalized mouse hepatic cell line[J]. Carcinogenesis, 2004, 25 (12):2 385-2 395.

同被引文献119

引证文献6

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部